Yohimban-16-carboxylic acid,11,17-dimethoxy-12-nitro-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)- (38955-89-4)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid,18-hydroxy-17-methoxy-,(3â,16â,17R,- 18â,20R)-
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-,methyl ester,(3â,16â,17R,20R)-
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with rel-3-(aminosulfonyl)-4-chloro-N-[(2R,6S)- 2,6-dimethyl-1-piperidinyl]benzamide and (5'R)-12'-hydroxy-2'-(1-methylethyl)-5'- (phenylmethyl)ergotaman-3',6',18-trione monomethanesulfonate (salt)
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with N-[(acetylamino)carbonyl]-2-bromo-2-ethylbutanamide and 3-(2-methylphenoxy)-1,2-propanediol
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide and 2,3-dihydro-1,4-phthalazinedione dihydrazone sulfate (1:1)
- Yohimban-16-carboxylic acid,18-ethoxy-11,17-dimethoxy-,methyl ester,(3â,16â,17R,18â,20R)-,(2Z)-2-butenedioate
- Yohimban-16-methanol,18-hydroxy-17- methoxy-,(3â,16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide,5-ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)- pyrimidinetrione monosodium salt and 2-(phenylmethyl)-1H-benzimidazole
- Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,(3â,16R,17R,20R)-
- Yohimban-16-carboxylic acid,17-hydroxy-9-methoxy-,(3â,16â,17â,- 20R)-
- Yohimbanium,16-carboxy-3,4-didehydro-18- hydroxy-11,17-dimethoxy-,(16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid,16,17-didehydro-,methyl ester,(3â,20R)-
- 18--HYDROXY-11, 17--DIMETHOXY-3-, 20--YOHIMBAN-16--CARBOXYLIC ACID, METHYL ESTER, 4-HYDROXY-3,5-DIMETHOXYBENZOATE (ESTER), ETHYLCARBONATE (ESTER)
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, mono[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetate]
- Yohimban-16-carboxylic acid, 1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, compd. with 5-oxo-l-proline (1:2)
- 18-Norspirosola-5,12-dien-3-ol,17-methyl-,(3â,16â,17â,22S,25S)-
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3b,20a)- (9CI)
- 18-Norpicrasan-1-one,11-[(1,3-benzodioxol- 5-ylcarbonyl)oxy]-16-(â-Dglucopyranosyloxy)- 2,12-dimethoxy-,(2R,11R,- 12â,16R)-
- Oxayohimban-16-carboxylic acid,16,17-didehydro-11-methoxy-19- methyl-,methyl ester,(3â,19â,20R)-
